An August 8, 2016 article titled “A cure for hepatitis C, if not for the cost” provides an in-depth look into the lives of various individuals living with Hepatitis C (HCV), as well as some who have been able to access the HCV cure. The article, published by The Bulletin in Oregon, features interviews with a variety of doctors, nurses, and advocates, including CHLPI’s Faculty Director Robert Greenwald.
Excerpt from article:
“Greenwald, the Harvard Law School professor, said treatment in many states, after rebates from drug manufacturers, costs Medicaid programs in the $30,000 range. For comparison, programs pay between $12,000 and $15,000 annually to keep HIV patients healthy, he said.
‘It’s fantastic that for that $15,000 a year, we can keep people healthy and live the rest of their life,’ he said. ‘In this case, we’re talking about a cure. One time, 12 weeks, one pill a day, for $30,000. That’s it.’”
Read “A cure for Hepatitis C, if not for the cost” in full.